Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Alzheimer's Disease

Free Subscription 04.11.2019 1 Alzheimers Dement 2 Ann Neurol 1 BMC Neurol 1 Brain Res 5 Curr Alzheimer Res 6 J Alzheimers Dis 1 J Neurochem 1 Nature 1 Neurobiol Dis 1 Neuroscience 1 Proc Natl Acad Sci U S A 1 Rev Neurol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Alzheimers Dement

1. OSSENKOPPELE R, Lyoo CH, Sudre CH, van Westen D, et al
   Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease.
   Alzheimers Dement. 2019 Oct 28. pii: S1552-5260(19)35375.
   PubMed     Text format     Abstract available
   
   

   
   Ann Neurol

2. PRINS S, Zhuparris A, Groeneveld GJ
   The Usefulness of Plasma Amyloid as a Prescreener for the Earliest Alzheimer Pathological Changes depends on the study population.
   Ann Neurol. 2019 Nov 1. doi: 10.1002/ana.25634.
   PubMed     Text format    
   
   
3. VERBERK IMW, Teunissen CE, Van der Flier WM
   Reply to "The Usefulness of Plasma Amyloid as Prescreener of the earliest Alzheimer Pathological Changes depends on the study population".
   Ann Neurol. 2019 Nov 1. doi: 10.1002/ana.25633.
   PubMed     Text format    
   
   

   
   BMC Neurol

4. ORTNER M, Drost R, Heddderich D, Goldhardt O, et al
   Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's disease.
   BMC Neurol. 2019;19:264.
   PubMed     Text format     Abstract available
   
   

   
   Brain Res

5. REALE M, Gonzales-Portillo I, Borlongan CV
   Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer's Disease: present and future applications.
   Brain Res. 2019 Oct 25:146535. doi: 10.1016/j.brainres.2019.146535.
   PubMed     Text format     Abstract available
   
   

   
   Curr Alzheimer Res

6. JAREMO P, Jejcic A, Jelic V, Shahnaz T, et al
   Erythrocyte amyloid beta peptide isoform distributions in Alzheimer and mild cognitive impairment.
   Curr Alzheimer Res. 2019 Oct 9. pii: CAR-EPUB-101313.
   PubMed     Text format     Abstract available
   
   
7. MANIVANNAN B, Yegambaram M, Supowit S, Beach TG, et al
   Assessment of persistent, bioaccumulative and toxic organic environmental pollutants in liver and adipose tissue of Alzheimer's disease patients and age- matched controls.
   Curr Alzheimer Res. 2019 Oct 10. pii: CAR-EPUB-101321.
   PubMed     Text format     Abstract available
   
   
8. KNEZ D, Sosic I, Pislar A, Mitrovic A, et al
   Biological Evaluation of 8-Hydroxyquinolines as Multi-Target Directed Ligands for Treating Alzheimer's Disease.
   Curr Alzheimer Res. 2019 Oct 10. pii: CAR-EPUB-101329.
   PubMed     Text format     Abstract available
   
   
9. MALEK R, Refouvelet B, Benchekroun M, Iriepa I, et al
   Synthesis and Biological Evaluation of Novel Chromone+Donepezil Hybrids for Alzheimer's Disease Therapy.
   Curr Alzheimer Res. 2019 Oct 11. pii: CAR-EPUB-101361.
   PubMed     Text format     Abstract available
   
   
10. ZENGA F, Li Y, Xua Y, Yanga J, et al
    Strategies targeting soluble beta-Amyloid oligomers and their application to early diagnosis of Alzheimer's Disease.
    Curr Alzheimer Res. 2019 Oct 31. pii: CAR-EPUB-102026.
    PubMed     Text format     Abstract available
    
    

    
    J Alzheimers Dis

11. SCHELTER BO, Shiells H, Baddeley TC, Rubino CM, et al
    Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 21. pii: JAD190772. doi: 10.3233/JAD-190772.
    PubMed     Text format     Abstract available
    
    
12. BOCCARDI V, Paolacci L, Remondini D, Giampieri E, et al
    Cognitive Decline and Alzheimer's Disease in Old Age: A Sex-Specific "Cytokinome Signature".
    J Alzheimers Dis. 2019 Oct 21. pii: JAD190480. doi: 10.3233/JAD-190480.
    PubMed     Text format     Abstract available
    
    
13. CLARK LR, Norton D, Berman SE, Johnson SC, et al
    Association of Cardiovascular and Alzheimer's Disease Risk Factors with Intracranial Arterial Blood Flow in Whites and African Americans.
    J Alzheimers Dis. 2019 Oct 21. pii: JAD190645. doi: 10.3233/JAD-190645.
    PubMed     Text format     Abstract available
    
    
14. 
    Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study.
    J Alzheimers Dis. 2019 Oct 21. pii: JAD199009. doi: 10.3233/JAD-199009.
    PubMed     Text format    
    
    
15. 
    Abeta42/Abeta40 and Abeta42/Abeta38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2019 Oct 21. pii: JAD199010. doi: 10.3233/JAD-199010.
    PubMed     Text format    
    
    
16. FUCHSBERGER T, Yuste R, Martinez-Bellver S, Blanco-Gandia MC, et al
    Oral Monosodium Glutamate Administration Causes Early Onset of Alzheimer's Disease-Like Pathophysiology in APP/PS1 Mice.
    J Alzheimers Dis. 2019 Oct 21. pii: JAD190274. doi: 10.3233/JAD-190274.
    PubMed     Text format     Abstract available
    
    

    
    J Neurochem

17. HASCUP ER, Broderick SO, Russell MK, Fang Y, et al
    Diet-induced insulin resistance elevates hippocampal glutamate as well as VGLUT1 and GFAP expression in AbetaPP/PS1 mice.
    J Neurochem. 2019;148:219-237.
    PubMed     Text format     Abstract available
    
    

    
    Nature

18. 
    Swine flu snipers, Alzheimer's drug push and Google's latest gaming bot.
    Nature. 2019;574:602-603.
    PubMed     Text format    
    
    

    
    Neurobiol Dis

19. ROYEA J, Martinot P, Hamel E
    Memory and cerebrovascular deficits recovered following angiotensin IV intervention in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2019;134:104644.
    PubMed     Text format     Abstract available
    
    

    
    Neuroscience

20. FRAGA VG, Magalhaes CA, de Mello Gomide Loures C, de Souza LC, et al
    Inflammatory and Pro-resolving Mediators in Frontotemporal Dementia and Alzheimer's Disease.
    Neuroscience. 2019 Oct 22. pii: S0306-4522(19)30653.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

21. CHEN ZL, Singh P, Wong J, Horn K, et al
    An antibody against HK blocks Alzheimer's disease peptide beta-amyloid-induced bradykinin release in human plasma.
    Proc Natl Acad Sci U S A. 2019 Oct 28. pii: 1914831116.
    PubMed     Text format     Abstract available
    
    

    
    Rev Neurol

22. COSSINI FC, Cuesta C, Rubinstein W, Politis DG, et al
    [Recognition of basic emotions and their main confusers in Alzheimer-type dementia].
    Rev Neurol. 2019;69:363-369.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: